loading page

Recurrent Arteriovenous Graft Thrombosis in COVID-19 Positive Patient
  • Namrata Singhania,
  • Saurabh Bansal,
  • Girish Singhania
Namrata Singhania
Mount Carmel East
Author Profile
Saurabh Bansal
University of Illinois College of Medicine at Peoria
Author Profile
Girish Singhania
University of Utah School of Medicine
Author Profile


Coronavirus disease 2019 (COVID-19) has been tied to many complications such as hypercoagulability. It is more commonly seen in patients admitted to intensive care unit. Herein, we report a case of an end stage renal disease patient who developed recurrent arteriovenous graft thrombosis in the setting of COVID-19.

Peer review status:ACCEPTED

11 Feb 2021Submitted to Clinical Case Reports
11 Feb 2021Submission Checks Completed
11 Feb 2021Assigned to Editor
11 Mar 2021Reviewer(s) Assigned
19 May 2021Review(s) Completed, Editorial Evaluation Pending
19 May 2021Editorial Decision: Revise Minor
17 Jun 20211st Revision Received
07 Jul 2021Submission Checks Completed
07 Jul 2021Assigned to Editor
07 Jul 2021Review(s) Completed, Editorial Evaluation Pending
08 Jul 2021Reviewer(s) Assigned
09 Aug 2021Editorial Decision: Accept